IL-21 Protein, Human
Based on 1 publication(s) in Google Scholar
IL-21 Protein, Human is a class 1 cytokine, which is produced by activated CD4+ T cells. IL-21 Protein stimulation of T cells, B cells and NK cells leads to enhanced proliferation and mature effector function.
- Species: Human
- Source: E. coli
-
Storage:Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.
Biological Activity
IL-21 Protein, Human is a class 1 cytokine, which is produced by activated CD4+ T cells. IL-21 Protein stimulation of T cells, B cells and NK cells leads to enhanced proliferation and mature effector function.
Interleukin-21 (IL-21) is a pleiotropic cytokine that has key functions in both the innate and adaptive immunity and the regulation of autoimmunity. IL-21 has a range of activities likely to potentiate antitumor immunoresponses. IL-21 has a role as a single agent in the treatment of melanoma. IL-21 also has significant activity against various types of cancer in combination with monoclonal antibodies or signaling inhibitors[1]. Recombinant human interleukin-21 (rIL-21), a human recombinant interleukin, with Cetuximab, a monoclonal antibody, targeting the epidermal growth factor receptor[2].
1.The ED50 is <0.5 ng/mL as measured by Mino cells, corresponding to a specific activity of >2.0 × 106 units/mg.
2.Measured by its binding ability in a functional ELISA. Immobilized Human IL-21R at 5 μg/mL (100 μL/well) can bind Human IL-21. The ED50 for this effect is 5.056 ng/mL.
3.Measured by its ability to enhance IFN-gamma secretion in NK-92 human natural killer lymphoma cells. The ED50 for this effect is 6.707 ng/mL.
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
Immunol Invest
Exploring the IL-21/IL-21R Signaling Pathway in Rheumatoid Arthritis: Implications for Synoviocyte Survival and Disease Progression. [Abstract]2025 Aug 4:1-24. PMID: 40759665
IL-21 Protein, Human purchased from MedChemExpress. Usage Cited in: Immunol Invest. 2025 Aug 4:1-24. [Abstract]
IL-21 Protein, Human (10 ng/mL, 20 ng/mL, and 40 ng/mL). Western blot analysis of the expression levels of IL-21R in HFLS-RA cells. β-actin was used as an internal reference protein.
IL-21 Protein, Human purchased from MedChemExpress. Usage Cited in: Immunol Invest. 2025 Aug 4:1-24. [Abstract]
IL-21 Protein, Human (10 ng/mL, 20 ng/mL, and 40 ng/mL). CCK-8 assay was employed to measure cell viability of HFLS-RA cells.
IL-21 Protein, Human purchased from MedChemExpress. Usage Cited in: Immunol Invest. 2025 Aug 4:1-24. [Abstract]
IL-21 Protein, Human (10 ng/mL, 20 ng/mL, and 40 ng/mL). Flow cytometry was utilized to analyze the apoptosis rate.
IL-21 Protein, Human purchased from MedChemExpress. Usage Cited in: Immunol Invest. 2025 Aug 4:1-24. [Abstract]
IL-21 Protein, Human (10 ng/mL, 20 ng/mL, and 40 ng/mL) . Transmission electron microscopy (TEM) was applied to observe the number of autophagosomes in HFLS-RA cells. Yellow arrow, autophagosome.
IL-21 Protein, Human purchased from MedChemExpress. Usage Cited in: Immunol Invest. 2025 Aug 4:1-24. [Abstract]
IL-21 Protein, Human (10 ng/mL, 20 ng/mL, and 40 ng/mL) . Western blot was conducted to detect the protein expression levels of GRP78, Caspase12, cleaved-Caspase12, CHOP.
IL-21 Protein, Human purchased from MedChemExpress. Usage Cited in: Immunol Invest. 2025 Aug 4:1-24. [Abstract]
IL-21 Protein, Human (10 ng/mL, 20 ng/mL, and 40 ng/mL) . Western blot was conducted to detect the protein expression levels of LC3II/LC3I, Beclin1, and p62. β-actin was used as an internal reference protein.
Technical Parameters
-
Species Human
-
Source E. coli
-
Tag Tag Free
-
Accession
Q9HBE4-1 (Q32-S162)
-
Molecular Construction
-
N-term
-
IL-21 (Q32-S162)
Accession # Q9HBE4-1 -
C-term
-
-
Protein Length
Partial
-
Synonyms
IL21; Interleukin-21; Interleukin 21; Interleukin; IL-21; CVID11; Za11
-
AA Sequence
QDRHMIRMRQLIDIVDQLKNYVNDLVPEFLPAPEDVETNCEWSAFSCFQKAQLKSANTGNNERIINVSIKKLKRKPPSTNAGRRQKHRLTCPSCDSYEKKPPKEFLERFKSLLQKMIHQHLSSRTHGSEDS
-
Predicted Molecular Mass
15.6 kDa
-
Molecular Weight
Approximately 15-16 kDa, based on SDS-PAGE under reducing conditions, due to the glycosylation.
-
Purity
≥ 95%, as determined by reducing SDS-PAGE.
Product Properties
Lyophilized powder.
1.Lyophilized from a 0.22 μm filtered solution of PBS.
2.Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4, 5% trehalose, 5% mannitol, 0.01% Tween 80.
3.Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4.
Please refer to the lot-specific COA for specific buffer information.
<1 EU/μg, determined by LAL method.
It is not recommended to reconstitute to a concentration less than 100 μg/mL in ddH2O. For long term storage it is recommended to add a carrier protein (0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose).
Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.
Room temperature in continental US; may vary elsewhere.
Documentation
-
Data Sheet (262 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2659 KB)
References
[1]. Davis ID, et al. Clinical and biological efficacy of recombinant human interleukin-21 in patients with stage IV malignant melanoma without prior treatment: a phase IIa trial. Clin Cancer Res. 2009 Mar 15;15(6):2123-9. [Content Brief]
[2]. Steele N, et al. A phase 1 trial of recombinant human IL-21 in combination with cetuximab in patients with metastatic colorectal cancer. Br J Cancer. 2012 Feb 28;106(5):793-8. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)